ArticleVaccines2021

Bone Marrow Transfer in Relapsing-Remitting EAE Ameliorates Disease at First Remission, with No Synergistic Effect upon Co-Transplantation with Mesenchymal Stem Cells.

Giovanni Ferrara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.